
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1166 | 1058 | 1165 | 1443 | 1957 | 1561 |
Fund Return | 16.57% | 5.83% | 16.48% | 13% | 14.37% | 4.55% |
Place in category | 24 | 31 | 44 | 19 | 21 | 78 |
% in Category | 10 | 14 | 15 | 4 | 10 | 51 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPMorgan Global Income A Div EUR | 16.91B | 1.12 | 1.94 | 1.73 | ||
JPM Global Income Fund A Mth EUR | 16.91B | 1.11 | 1.92 | - | ||
JPMorgan Global Income D div EUR | 16.91B | 0.98 | 1.58 | 1.37 | ||
JPM Global Income A acc EUR | 16.79B | 1.12 | 1.94 | 1.72 | ||
LU0740858492 | 16.79B | 0.97 | 1.58 | 1.37 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Allianz Glbl Inv Euro Eq div W EUR | 1.86B | 10.74 | 11.22 | 4.33 | ||
LU0971552913 | 1.83B | 10.20 | 9.91 | 3.11 | ||
LU0414045582 | 1.81B | 10.20 | 9.91 | 3.10 | ||
LU0414046390 | 1.81B | 9.86 | 9.09 | 2.33 | ||
BlackRock European Equity IncomeE5G | 1.63B | 10.67 | 9.24 | 4.29 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SAP | DE0007164600 | 2.79 | 255.150 | +1.39% | |
JPMorgan Liquidity Funds Euro Liquidity Fund X ( | LU0836346931 | 2.33 | 10,703.830 | +0.01% | |
Roche Holding Participation | CH0012032048 | 2.23 | 263.40 | +0.50% | |
Novartis | CH0012005267 | 2.19 | 97.12 | +1.15% | |
HSBC | GB0005405286 | 1.74 | 879.80 | +0.49% |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | - | - | - | Sell | Buy |
Technical Indicators | - | - | - | Strong Sell | Strong Buy |
Summary | Neutral | Neutral | Neutral | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review